Modernizing the Mitral Valve: Advances in Robotic and Minimally Invasive Cardiac Repair

Similar documents
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches

Applications of Proton Therapy for Breast Cancer

Complex Retrieval of Embedded Inferior Vena Cava Filters in Interventional Radiology

Bridging The Cardiology Gap: Care Priorities for Adults With Congenital Heart Disease

Who is at Risk for Pulmonary Arterial Hypertension (PAH)?

The Biomechanical Approach to Heart Disease

Hepatocellular Carcinoma: Clinical Priorities from Detection to Liver Transplantation

The Future of Deep Brain Stimulation for Parkinson's Patients and Beyond

The Next Horizons in Reconstructive Microsurgery

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice

Incisionless Brain Surgery

Heated Intraperitoneal Chemotherapy (HIPEC) for Advanced Abdominal Cancers

Treating the Female Athlete: Sports Medicine Updates for Women, by Women

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches

Carotid Ultrasound Scans for Assessing Cardiovascular Risk

Expert Tips for Diagnosis and Management of Bacterial Vaginosis

Deciphering Chronic Pain and Pain Medicine

Prostatic Cryosurgery and Robotic Prostatectomy

Fight-or-Flight: Understanding Our Body's Response to Adrenaline

4 Latest Advances in Epilepsy Treatment at Penn

Addressing Vascular Plaque Ruptures

CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

Ultra-Portable Ultrasound in the Critical Care Unit

Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease

Addressing Breast Cancer's High Recurrence Rates: The Breast Cancer Translational Center of Excellence (TCE)

Comparing Liquid-Based Cytology Methods in the Detection of Cervical Cancer: Perspectives from Dr. Daniel Ferrante

A More Definitive Ablation Procedure for Atrial Fibrillation

Sexual Function and Fertility in Men After Cancer

Laparoscopic Surgical Approaches for Ulcerative Colitis

Can Angioplasty Improve Quality of Life for CAD Patients?

Cardiovascular Controversies: Exploring the ACC and AHA Guidelines on the Treatment of Blood Cholesterol

Advanced Chronic Kidney Disease and Secondary Hyperparathyroidism (HPT): Multidisciplinary Management

Current Management Strategies for Atrial Fibrillation

Detect Cervical Cancer ReachMD Page 1 of 7

Unraveling Recent Cervical Cancer Screening Updates and the Impact on Your Practice

Sickle Cell Disease: How Should YOU Reassess Management & Treatment?

Normalizing STI Screening: The Patient Impact

The Role of the Certified Diabetes Educator: A Team Effort

The World s Smallest Heart Pump

Rotator Cuff Tears: New Understandings

Robotic Hybrid Coronary Revascularization

Smoking Cessation Strategies for the 21st Century

Uncontrolled Moderate-to-Severe-Asthma: Latest Data from the Floor of CHEST 2018

I don t want to be here anymore. I m really worried about Clare. She s been acting different and something s not right

The Expanding Value of Biomarkers in NSCLC Treatment

The HPV Data Is In What Do the Newest Updates in Screening Mean For Your Patients?

Cerebrovascular Neurosurgery: The Highly Specialized Care for All Aspects of Cerebrovascular Disease

The Real Story on Stents: A Bright Future?

PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects

Cranial Base Disorders: Etiologies, Surgical Approaches, and Research Innovations

What IPF Really Means: Discussions with Caregivers, Patients, & Healthcare Providers

The Use of TORS for HPV-Related Oropharynx Cancer

Comprehensive Smoking Cessation Programs

Aspirin Resistance and Its Implications in Clinical Practice

Neonatal Diabetes: A Special Case of Type 1 Diabetes

Genotype Testing on Current Cervical Cancer Algorithms

Active Living with Arthritis Podcast #9 Being a Caregiver: Caring for Someone and Managing Your Arthritis

Breast Cancer Screening: Improved Readings With Computers

Exertional Heat Stroke (EHS): Emergency Medical Treatment Goals

Childhood Stroke: Risk Factors, Symptoms and Prognosis

Does Every Knee Need a Meniscus?

Ultrasound: Improving Breast Cancer Detection

Technologies and Methods for Visualizing the Retina

Exploring the Patient Journey: Let s Talk About ILD and IPF

Hereditary Cancer Syndromes and the Obstetrician/Gynecologist

An Update on BioMarin Clinical Research and Studies in the PKU Community

Beyond The Data: Promoting Well-being in Older Adults

Debulking Surgery and HIPC to Treat Ovarian Cancer

Before beginning this activity, be sure to review the faculty and commercial support disclosures, as well as the Learning Objectives.

Ginkgo Biloba: How Supportive is the Data?

Extraesophageal GERD: Fact or Fiction?

Investigating Plinabulin for Prevention of Chemotherapy-Induced Neutropenia

Global Perspectives on Organ Donation

Less Invasive Options for Pulmonary Testing

Active Living with Arthritis Podcast #11 Doing What You Love: Gardening, Golf, and Tennis when Living with Knee Osteoarthritis

Anesthetic Management of Patients Undergoing Spine Surgery

Addressing Information Gaps in Advanced Prenatal Screening: What Your Expecting Patients Need to Know

Roles of Non-HDL Cholesterol in Risk Assessment and Treatment

Carrier Screening in your Practice Is it Time to Expand your View?

UW MEDICINE PATIENT EDUCATION. Hemodialysis. A treatment option for kidney disease. Treatment Options for Kidney Disease

A Look at Psychosocial Issues Post MI and With ICD

You re listening to an audio module from BMJ Learning. Hallo. I'm Anna Sayburn, Senior Editor with the BMJ Group s Consumer Health Team.

Type 1 Diabetes: Control and Cure

The ERA JUMP Study: Reevaluating the Omega- 3 Index

Hybrid Arch Debranching

Peripheral Artery Disease: How New Stent Options are Revolutionizing Care

Using New Guidelines to Improve Best Practices in Obesity Management

Lung Cancer Awareness Month Update 2008

The Diabetes Breakthrough: Dr. Osama Hamdy on his 12-week Plan

Mental Health Screening: Cystic Fibrosis Foundation Guidelines and Specific Recommendations: The Benefits and Risks

Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines

Combining Individualized Treatment Options with Patient-Clinician Dialogue

Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis

Advanced Cholesterol Testing

What is the Economic Impact of Autism Spectrum Disorder?

How To Treat Resistant Bipolar Patients

The Parent's Perspectives on Autism Spectrum Disorder

The New GERD Guidelines

Heart Attack Recovery: Understanding the World s Smallest Heart Pump Webcast February 4, 2009 Antony Kim, M.D.

Nontuberculous Mycobacteria (NTM) in Patients with Cystic Fibrosis

Transcription:

Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/modernizing-mitral-valveadvances-robotic-minimally-invasive-cardiac-repair/7686/ ReachMD www.reachmd.com info@reachmd.com (866) 423-7849 Modernizing the Mitral Valve: Advances in Robotic and Minimally Invasive Cardiac Repair Narrator: Welcome to Medical Breakthroughs from Penn Medicine, Advancing Medicine Through Precision Diagnostics and Novel Therapies. What are the latest advances in minimally invasive and robotic operations, and which patients are candidates for robotic procedures? You re listening to ReachMD and I m your host, Dr. Jennifer Caudle. And with me today is Dr. Pavan Atluri, Assistant Professor of Surgery. He is also the Director of the Cardiac Transplantation and Mechanical Circulatory Assist Program and he is the Director of the Minimally Invasive and Robotic Cardiac Surgery Program in the Division of Cardiovascular Surgery at the University of Pennsylvania. Dr. Atluri, welcome to the program. Thank you and thank you for inviting me. 2018 ReachMD Page 1 of 7

Well, we re happy to have you today. So, we re talking about minimally invasive and robotic operations. Can you tell us what the advantages of these procedures are? Yes, I think there are several advantages; the first and probably the least important of which is cosmesis, but of course the incision is markedly smaller and allows people really to have the operation and postoperatively really be unrecognized from an operative standpoint, as opposed to the old days where there was a big scar down the middle of the chest. The other advantages really are in terms of recovery. It s a much more rapid recovery, and really, several of my patients will be ready to resume normal activities within a couple of weeks of surgery, and that includes going back to work and really partaking in their daily activities. So, it s been a really nice improvement in terms of how quickly patients bounce back from the operation. That s interesting. Can you talk to us about really what s involved with a robotic operation? I often get the question, what are you doing if the robot is doing the operation, which is always sort of an interesting question, but really speaking, the robot is an extension which allows us to work through some very small ports. There are two robotic arms which both go through a 7 mm port and then a very small limited working incision between 2 to 2.5 cm. The conduct of the operation involves the bedside surgeon who, my partner, whoever is at the operative side of the table, and then I m working at the robot. The robot itself has got several advantages over the current laparoscopic or thoracoscopic operations in that it s got, first and foremost, it has 3-dimensional vision that takes 2 separate images; one that is at the left eye and the other the right eye, merges it together to provide a 3-dimensional image within the console. And the second, is that it really provides the wrist and the finite motion back that disappears with straight-shafted instruments from traditional small-incision thoracoscopic surgery. So, really, it gives us a lot more precision and an ability to work through small spaces. Oh, that s interesting. So with that, with that precision that you have and sort of the ability to almost take surgery to another level, sort of what you re describing, what procedures can be performed robotically? 2018 ReachMD Page 2 of 7

Yes, there are actually several. The most common that we do is the robotic mitral valve operation and that includes both repairs as well as replacements. It can also involve repairs of holes in the heart or atrial septal defects. We ve excised tumors from inside the heart. We can also operate on the tricuspid valve. Outside of the heart, we re able to do bypass surgery through small incisions and avoid the traditional sternotomy or zipper that goes along with the coronary artery bypass grafting procedure. That s interesting. And how might you decide which surgeries you choose to perform robotically versus a different way? You know, are there certain criteria, or certain things that you think about, besides the cosmesis and recovery that you mentioned in the beginning? Yes, absolutely. You know, at the end of the day, it always comes down to patient preference and I really try to spend a lot of time with patients, telling them the risks and benefits of the operation, really go through what s involved. And that first step is really for the patient to decide, hey, this is something I want to do, and then after that we go through a fairly extensive screening process to make sure that we avoid any of the pitfalls that may arise. And that may include a CAT scan to make sure there isn t too much calcium within the aorta that could cause complication, any possible risk factors for stroke; basically anything that we ve learned over the last 1400 cases that we ve done that could contribute to a problem. Sure. Just out of curiosity, what is the cardiac procedure that you tend to perform most minimally invasively or robotically? It s the mitral valve operation. Mitral valve repair procedure. If you re just tuning in, you are listening to Medical Breakthroughs from Penn Medicine on ReachMD. I m your host, Dr. Jennifer Caudle, and I m speaking with Dr. Pavan Atluri, Director of Minimally Invasive and Robotic Cardiac Surgery Program at the University of Pennsylvania. So, let s go back a little bit. Let s take a step backwards, because we re talking about minimally invasive and robotic procedures, especially as it relates to cardiac surgery. You mentioned a little bit about patient preference and patient candidacy. Can you speak a little bit more about which patients are candidates 2018 ReachMD Page 3 of 7

for robotic procedures and maybe talk a little more in depth about maybe who wouldn t be and who is, especially for some of the work that you do? Yes, you know, I will say patients more often than not are, in fact, candidates for the procedure. There is a very small population of patients that are not well suited for robotic procedures and that would include, it really depends on the operation that s being performed, but for the coronary side of things, patients that have disease in several of the vessels in the heart, and the robot really allows us to get to the top of the heart and just to the side of the heart, so any time that we would need to do revascularization or provide blood flow to the other parts of the heart, we really tend to shy away from it if it s too extensive. If it s disease in two territories, we ll oftentimes do the robotic bypass surgery and then the additional territory is taken care of with an angioplasty or stent. But if there are too many territories involved, the last thing we want to do is leave someone with a small incision but not have the heart fully revascularized. So, that is one patient population. When we talk about the procedures within the heart, the ASD, the mitral valve, the tricuspid valve, or the tumors, then we really want to make sure that there isn t too much calcium within the aorta that would either lead to a stroke or a tearing of the aorta, known as a dissection. Both are very low incidences and extremely rare, but nonetheless something that we screen for, because if you are that extremely rare patient then it might as well be 100% certainty for you. So, we re very careful to make sure that we select those patients with heavy calcium burdens or atherosclerotic burdens and shy away from the procedure. And the other real big population is the patients that have extensive calcium, known as mitral annular calcification, around the mitral valve, and the patients are at significantly increased risk for something known as AV disruption or atrioventricular disruption. Literally the bottom ventricular portion of the heart separates from the top atrial portion. So, those patients really should not be treated minimally invasively and should really be treated with an open operation. And, in fact, those operations should really be performed at centers of mitral valve excellence, like the University of Pennsylvania by surgeons like myself, Mike Acker, Clark Hargrove, that are highly skilled and experienced in dealing with patients with that scenario. You know, that was actually something I wanted to ask you, if you don t mind is, how common, the ability to do these procedures robotically or minimally invasively for the heart? Is this common throughout the country or is Penn sort of one of the unique centers that does these types of procedures? 2018 ReachMD Page 4 of 7

We re fairly unique. I ve got a lot of friends within the robotic community and I feel like I basically know everybody in the robotic community; it s such a small community. In talking to Intuitive, the company that actually supports the robot, I get a very clear sense of the number of people in the country that are doing robotic procedures, and it s a couple of dozen people around the country. So, it s a very limited operation. Absolutely. It s very highly specialized. One of the things I wanted to ask specifically about is the mitral valve. So, maybe we can talk specifically about mitral valve repairs. You know, are mitral valves repaired with the same techniques robotically for example, as when performed with a sternotomy? Maybe you can speak about that in particular and contrast and compare. We try to follow the same exact principles for repair because at the end of the day what we re really striving for is excellent longterm data. We don t want to perform a procedure through a small incision and compromise on the quality of the repair. So, when we perform a repair, first and foremost, we try to repair every valve. Our success rate is close to 100% at the University of Pennsylvania with valve repairs, which is significantly higher than the rest of the country. A lot of that comes from the experience that we have and a lot of it also comes for following appropriate principles for mitral valve repair. So, whether sternotomy or minimally invasively, we follow the same exact procedure and techniques for repairing the valve. The other thing that we really strive for is really good longterm data, not just immediate repair, but really we want to get these patients out for their entire life. If they re 30 years old, we want to get them into their 80s or 90s. Sure, of course, the success of the procedure is of utmost importance. Absolutely. I had a question about recovery time because that was sort of one of the things you mentioned in the beginning about some of the advantages to minimally invasive and robotic operations. Can you maybe give us an example of a cardiac procedure that might be done non-robotically or minimally invasive, versus one that is, and maybe the difference in recovery time or length of stay or what might be expected from the patient? That s a great question. I just found out that one of our papers that we submitted was just accepted for publication and the premise behind the paper was really to ask that exact question is, what is the 2018 ReachMD Page 5 of 7

difference in length of stay? Well, congratulations I should say. Thank you. But it s about a day and a half shorter in terms of overall hospital length of stay. On average, patients stay about 4½ days after the minimally invasive mitral valve procedure, compared to about 6 days for the sternotomy procedure. Is there a difference in complication rates that you ve also noted, or were you not looking at that in this particular paper? Yes, so complication rates are very similar and low for both, but the one major difference that we found is that there appears to be a lower tendency for blood transfusion, and along with that, anecdotally, we also notice much less bleeding with minimally invasive and robotic operations. Absolutely. Well you know, it s really interesting and I think you really shed a lot of light on especially cardiac procedures and the advantages of minimally invasive and robotic operations. You know, is there anything else that you d like to add today about these procedures and maybe the work that you do? I would say, you know, it s new technology. I think it s important that, there are a lot of people that attempt it, and from a patient standpoint, it is very important to go to a center where there s really focus on the mitral valve in particular, and someone who s really got a lot of expertise in the mitral valve. That makes a lot of sense. Dr. Atluri, thank you so much for being with us today and sharing your insights on, you know, robotic and minimally invasive mitral valve repair procedures, as well as other procedures. 2018 ReachMD Page 6 of 7

Thank you. I m your host, Dr. Jennifer Caudle, and thank you so much for listening. Narrator: You ve been listening to Medical Breakthroughs from Penn Medicine. To download this podcast or to access others in the series, please visit ReachMD.com/Penn and visit Penn physician link, an exclusive program that helps referring physicians connect with Penn. Here you can find education resources, information about our expedited referral process, and communication tools. To learn more, visit www.pennmedicine.org/physicianlink. Thank you for listening. 2018 ReachMD Page 7 of 7